TheEdgeResearch
Home / Stocks / WILYY

Demant A/S (WILYY)

OTC Healthcare Medical - Devices
$22.62 ▲ +3.43%
Market Cap
$9.54B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.75
52-Wk Range
13.45-22.62
CEO
Søren Nielsen
Country
DK
Currency
USD

Demant A/S operates in the Medical - Devices industry of the Healthcare sector, headquartered in Smorum, ZE, DK. The stock last traded at $22.62, up 3.43% on the session, giving a market capitalisation of $9.54B. On trailing twelve-month figures it carries a trailing P/E of 39.29, a net margin of 6.7%. Its beta of 0.75 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
39.29
Price / Sales
2.65
Price / Book
6.20
EV / EBITDA
16.22
Gross margin
69.9%
Operating margin
17.6%
Net margin
6.7%
Return on equity
Debt / equity
2.39
Current ratio
1.33
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
26,704
IPO date
2011-06-24
Headquarters
Smorum, ZE, DK
About Demant A/S

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Comparable companies

Demant A/S is most often compared with the following Healthcare names:

BDUUFESAIYESALFGIFOFGNGBYMSMKFSHPMFSHTDYSSMXFSSMXY
More research on WILYY
WILYY technical analysis WILYY TheEdge Score Compare against peers
Open full interactive analysis & DCF →